Microbot Medical Inc.

Stage 4 · Declining · week 23

As of Oct 22, 2026, Microbot Medical is in Stage 4, the downtrend phase, now in week 23 (since May 15, 2026). It closed at $0.94, 67.0% below its 52-week high and below its 200-day average, which is falling.

$0.94

-1.31% today

$63.3M · Micro cap

Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is MBOT early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S4 19w

S4 22w

S4 15w

S2 26w

S4 14w

S4 23w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S1 1w → S4 19w → S1 5w → S4 22w → S1 5w → S4 15w → S1 5w → S2 13w → S3 4w → S2 26w → S3 5w → S4 14w → S1 9w → S4 23w current

Total tracked: 166 weeks across 14 stage runs.

MBOT among Medical Devices99th of 141 by relative strength

All 141 →

Stocks in Medical Devices ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	TXG10x Genomics, Inc.	Stage 2 · wk 48	99	−7.8%
2	RCELAvita Medical, Inc.	Stage 2 · wk 13	98	+40.8%
3	BFLYButterfly Network, Inc. Class A	Stage 2 · wk 26	98	−26.0%
4	HAEHaemonetics Corporation	Stage 2 · wk 17	96	+8.7%
5	GKOSGlaukos Corporation	Stage 2 · wk 25	96	+15.1%
6	AXGNAxogen, Inc.	Stage 3 · wk 2	95	−15.3%
7	NEOGNeogen Corporation	Stage 2 · wk 14	95	−11.7%
8	BVSBioventus Inc. Class A	Stage 2 · wk 15	95	+10.5%
…99	MBOTMicrobot Medical Inc.	Stage 4 · wk 23	17	−28.2%

vs 52W High

-67.0%

$0.94 lo$2.85 hi

67.0% below 52W high, deep Stage 4 damage

In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.

Stage Maturity

Week 23

1w13w26w

Week 23, extended decline

How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.

vs 200 DMA

-50.0%

200 DMA: $1.88 · sloping down

In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.

Rel Volume

0.44x

vs 50-day avg

High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.

Trend Health

↓

Short-term trend rolling over

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

-28.2%

-45.0%

-56.9%

YTD

-55.5%

-64.8%

Scan Membership

Breakout Watch

Latest: 2025-04-29

7 appearances in last 60 days. First seen: 2019-03-12.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S4

Wk 23 · Vol 0.44x

2026-10-21S4

Wk 22 · Vol 0.66x

2026-10-20S4

Wk 22 · Vol 1.02x

2026-10-19S4

Wk 22 · Vol 0.55x

2026-10-16S4

Wk 22 · Vol 1.14x

2026-10-15S4

Wk 22 · Vol 2.05x

2026-10-14S4

Wk 21 · Vol 0.82x

2026-10-13S4

Wk 21 · Vol 0.56x

2026-10-12S4

Wk 21 · Vol 0.61x

2026-10-09S4

Wk 21 · Vol 0.93x

2026-10-08S4

Wk 21 · Vol 0.82x

2026-10-07S4

Wk 20 · Vol 0.93x

Moving averages & range

50 DMA

$1.31

200 DMA

$1.88

52W High

$2.85

52W Low

$0.94

5D Low

$0.94

Resistance levels (recent highs)

20d High

$1.28

60d High

$1.94

120d High

$2.19

250d High

$2.85

Next resistance

+36.2%

to 20d High

ROE

-32.9%

Profit margin 0.0%

Dividend Yield

0.00%

P/B 0.9

Microbot Medical: quick answers

What stage is Microbot Medical in?

As of Oct 22, 2026, Microbot Medical (MBOT) is in Stage 4, the downtrend phase. It entered Stage 4 on May 15, 2026 and is in week 23. What the four stages mean

Is Microbot Medical in an uptrend?

No. Microbot Medical is in a Stage 4 downtrend. It trades 50.0% below its 200-day average, which is falling.

How far is Microbot Medical from its 52-week high?

Microbot Medical closed at $0.94 on Oct 22, 2026, 67.0% below its 52-week high of $2.85. Its 52-week low is $0.94.

How has Microbot Medical performed over the past year?

As of Oct 22, 2026, Microbot Medical is down 64.8% over the past year and down 55.5% so far in 2026.

Which sector and industry is Microbot Medical in?

Microbot Medical is in the Medical Devices industry, part of the Health Care sector.

About this companyHealth Care· Medical Devices

Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system designed to maneuver guidewires and over-the-wire devices, such as microcatheters within the body's vasculature for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system; and Emory University, in connection with autonomous robotics in endovascular procedures. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.